KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) EBT (2016 - 2025)

Clorox has reported EBT over the past 17 years, most recently at $215.0 million for Q4 2025.

  • Quarterly results put EBT at $215.0 million for Q4 2025, down 9.28% from a year ago — trailing twelve months through Dec 2025 was $986.0 million (up 52.4% YoY), and the annual figure for FY2025 was $1.1 billion, up 170.85%.
  • EBT for Q4 2025 was $215.0 million at Clorox, up from $107.0 million in the prior quarter.
  • Over the last five years, EBT for CLX hit a ceiling of $410.0 million in Q2 2025 and a floor of -$245.0 million in Q1 2023.
  • Median EBT over the past 5 years was $133.0 million (2022), compared with a mean of $134.2 million.
  • Biggest five-year swings in EBT: crashed 222.5% in 2023 and later soared 704.76% in 2025.
  • Clorox's EBT stood at $93.0 million in 2021, then surged by 39.78% to $130.0 million in 2022, then rose by 4.62% to $136.0 million in 2023, then skyrocketed by 74.26% to $237.0 million in 2024, then dropped by 9.28% to $215.0 million in 2025.
  • The last three reported values for EBT were $215.0 million (Q4 2025), $107.0 million (Q3 2025), and $410.0 million (Q2 2025) per Business Quant data.